Acute nonlymphocytic leukemia.
D002273:Carcinogens; D003520:Cyclophosphamide / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced
D002273:Carcinogens; D004317:Doxorubicin; D003520:Cyclophosphamide